1. Nie, Zhi, Cai, Shan, Wei, Zhimin, Wang, Xiangpeng, Wang, Chunyan. 2021. SH3GL3 acts as a novel tumor suppressor in glioblastoma tumorigenesis by inhibiting STAT3 signaling. In Biochemical and biophysical research communications, 544, 73-80. doi:10.1016/j.bbrc.2021.01.040. https://pubmed.ncbi.nlm.nih.gov/33524871/
2. Lin, Zhongkun, Liu, Zhiping, Tan, Xiansheng, Li, Chunhua. 2020. SH3GL3 functions as a potent tumor suppressor in lung cancer in a SH3 domain dependent manner. In Biochemical and biophysical research communications, 534, 787-794. doi:10.1016/j.bbrc.2020.10.107. https://pubmed.ncbi.nlm.nih.gov/33168185/
3. Tan, Li-Jun, Li, Xiao-Hua, Li, Gai-Gai, Chen, Xiang-Ding, Deng, Hong-Wen. 2021. Identification of novel pleiotropic gene for bone mineral density and lean mass using the cFDR method. In Annals of human genetics, 85, 201-212. doi:10.1111/ahg.12438. https://pubmed.ncbi.nlm.nih.gov/34115876/
4. Zhao, Yan, Lin, Shuo. 2013. Essential role of SH3-domain GRB2-like 3 for vascular lumen maintenance in zebrafish. In Arteriosclerosis, thrombosis, and vascular biology, 33, 1280-6. doi:10.1161/ATVBAHA.112.301025. https://pubmed.ncbi.nlm.nih.gov/23539215/
5. Wang, Jing, Kong, Peng-Fei, Wang, Hai-Yun, Li, Chuan-Ying, Shao, Jian-Yong. 2020. Identification of a Gene-Related Risk Signature in Melanoma Patients Using Bioinformatic Profiling. In Journal of oncology, 2020, 7526204. doi:10.1155/2020/7526204. https://pubmed.ncbi.nlm.nih.gov/32411243/
6. Chen, Ruoying, Zhao, Hong, Wu, Dan, Zhao, Weiling, Zhou, Xiaobo. . The role of SH3GL3 in myeloma cell migration/invasion, stemness and chemo-resistance. In Oncotarget, 7, 73101-73113. doi:10.18632/oncotarget.12231. https://pubmed.ncbi.nlm.nih.gov/27683032/
7. Kim, Yona, You, Ji Hyeon, Ryu, Yeonjoo, Park, Sung-Hye, Paek, Sun Ha. 2024. ELAVL2 loss promotes aggressive mesenchymal transition in glioblastoma. In NPJ precision oncology, 8, 79. doi:10.1038/s41698-024-00566-1. https://pubmed.ncbi.nlm.nih.gov/38548861/